Hepatitis B Core-Related Antigen is a Biomarker for off-Treatment Relapse After Long-Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B

OBJECTIVE: It remains unknown how to stratify the risk of clinical relapse of chronic hepatitis B (CHB) patients after stopping nucleos(t)ide analogs (NAs) antiviral therapy. METHODS: The current post hoc analysis included 122 non-cirrhotic patients with chronic hepatitis B virus infection who were...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Guichan, Ding, Xia, Xia, Muye, Wu, Yin, Chen, Hongjie, Fan, Rong, Zhang, Xiaoyong, Cai, Shaohang, Peng, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409517/
https://www.ncbi.nlm.nih.gov/pubmed/34483685
http://dx.doi.org/10.2147/IJGM.S321253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409517/
https://www.ncbi.nlm.nih.gov/pubmed/34483685
http://dx.doi.org/10.2147/IJGM.S321253

Ejemplares similares